CClinicalTrials.gg
CompletedNCT07418788Updated Sep 18, 2026

Polymeric Nano Calcium Fluoride Varnish, Diode Laser, and Their Combination for Dentin Hypersensitivity

An interventional study of Olinano seal and Diode Laser in Dentin Hypersensitivity, Non-carious Cervical Lesions and Gingival Recession Localized Moderate, sponsored by Faculty of Dental Medicine for Girls. Completed at 1 site in Egypt. Open to participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Faculty of Dental Medicine for Girls · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Study summary

The aim of the study is to assess the effect of polymeric nano calcium fluoride Varnish (Oli-NANO seal), 976 nm diode laser solely and combination of both therapies in the treatment of dentin hypersensitivity

02

Conditions studied

  • Dentin Hypersensitivity, Non-carious Cervical Lesions
  • Gingival Recession Localized Moderate

Browse trials for

Keywords

  • Dentin Hypersensitivity
  • Laser
  • Olinano Seal
  • Dual Treatment
03

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Medically free

    • Non-smokers
    • Co-operative patients who will be interested in participating in the study and willing to sign the informed consent.
    • Availability of patients for 1 year

Exclusion criteria

Exclusion Criteria:

  • Patients currently using analgesic, anti-inflammatory medications, sedatives, tranquilizers, anticonvulsants, or any other medications that could potentially alter pain perception.

    • Patients undergoing orthodontic treatment.
    • Patients using desensitizing toothpaste
    • Patients receiving dentin hypersensitivity (DH) treatment
    • Pregnant or lactating women
    • Patients have high consumption of sour and acidic food
    • Patients who had undergone professional desensitizing therapy during the previous 3 months.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Group 1 (OliNano Seal)

    OliNano Seal (polymeric nano calcium fluoride containing varnish)

    Other: Olinano seal

  • Active comparator
    Group 2 (Diode laser)

    Diode laser

    Device: Diode Laser

  • Experimental
    Group 3 (OliNano Seal and Diode laser)

    OliNano Seal and Diode laser

    Other: Olinano seal and Diode Laser

Interventions

  • OtherOlinano seal

    The OliNANO seal is "varnish-like" shield which is based on nanotechnology that allows an optimum adhesion to enamel and dentin, it could be used as an effective desensitizing agent by forming a protective layer that occludes the dentinal tubules which can be effective for a year as mentioned by the manufacturer. Polymeric nano calcium fluoride varnish consists of four main components, silicone polymer, NANO-fluorapatite, nano-calcium fluoride and amine fluoride (Olaflur)

  • DeviceDiode Laser

    increase in the metabolic activity of odontoblasts. Thus, obliteration of the dentinal tubules and formation of tertiary dentin.

  • OtherOlinano seal and Diode Laser

    Combined methods have been also evaluated in some previous studies. It showed more effect in reducing Dentin hypersensitivity than using every treatment solely

05

What researchers measure

Primary outcomes

  1. Pain severity

    The pain will be assessed using the (VAS) scale. The VAS is a scale that allows the patient to self-assess the pain felt by means of a line in which the patient marks the pain level "no pain" to the "maximum pain". 0: low pain, 1 - 3: moderate pain: 4 - 6, intense pain: 7 - 9, extremely intense pain: 10

    Time frame: Before the treatment (Baseline), after the first session (T1), second session (T2) will be done after a week from the first session, after 3 months (T3), 6 months (T6), 9 months (T9) and 12 months (T12)

06

Study locations

1 site
  • Faculty of Dental medicine for Girls
    Cairo, 4470351, Egypt
07

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07418788
Lead sponsor
Faculty of Dental Medicine for Girls
Responsible party
Basant Bahaa El Din Ibrahim (Assistant Lecturer of Restorative Dentistry, Misr International University) — Principal investigator
First posted
Feb 18, 2026
Start date
May 15, 2025
Primary completion
Jul 10, 2025
Completion
Jul 16, 2026
Last update
Sep 18, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion